ReSTORing good vision

Article

The diffractive AcrySof ReSTOR (Alcon) intraocular lens (IOL) can provide stable, high levels of spectacle independence for both near and distance vision.

The diffractive AcrySof ReSTOR (Alcon) intraocular lens (IOL) can provide stable, high levels of spectacle independence for both near and distance vision, according to Rudy Nuijts and colleagues from the Academic Hospital Maastricht, The Netherlands.

A total of 45 eyes of 23 patients who received the ReSTOR SA60D3 IOL were followed in a prospective trial. Patients were assessed preoperatively and six months and three years postoperatively.

No significant changes in uncorrected distance visual acuity (UCDVA) and best corrected distance visual acuity (BCDVA) were noted between the six month and three year time points.

At six months postoperatively, 78% and 83% of patients no longer required spectacles for near and distance vision respectively. At three years 73% and 74% of patients still did not require spectacles for near and distance vision, respectively. Near vision without glasses at six months and three years was 4.0 and 3.7, respectively and 4.3 and 3.8 for distance vision, respectively. Ninety percent of subjects declared themselves to be satisfied with intermediate vision tasks at both time points. Moderate to severe glare was reported by 9.9% and 4.3% at six months and three years and halos were reported by 8.7% and 4.3%, respectively.

Dr Nuijts and his colleagues concluded that the ReSTOR lens achieves excellent near and distance visual results in the majority of patients.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.